Medscape InDiscussion: Psoriasis: Recent Episodes
Medscape
Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986130). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep6-2026a10006hq. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/40991259/
Evaluating Psoriasis With Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment https://pubmed.ncbi.nlm.nih.gov/15389191/
International Psoriasis Council https://psoriasiscouncil.org/
Mediterranean Diet and Cardiovascular Health: Teachings of the PREDIMED Study https://pubmed.ncbi.nlm.nih.gov/24829485/
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39319513/
PCORI — Patient-Centered Outcomes Research Institute https://www.pcori.org/
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial https://pubmed.ncbi.nlm.nih.gov/29776990/
The Health Benefits of UV Radiation Exposure Through Vitamin D Production or Non-Vitamin D Pathways. Blood Pressure and Cardiovascular Disease https://pubmed.ncbi.nlm.nih.gov/28009890/
Using Guidelines of Care to Lower Cardiovascular Risk in Patients With Psoriasis https://pubmed.ncbi.nlm.nih.gov/38796273/
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis (CP3) Study: Preliminary Results https://www.med.upenn.edu/gelfand/assets/user-content/documents/cp3-isidposter2023-an.pdf
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Dr Faranak Kamangar joins Dr Steven Feldman to discuss how AI tools are cutting psoriasis admin hours, improving diagnostic accuracy, and freeing clinicians for more patient-facing care.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep5-2026a10006hn. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
DermGPT https://www.dermgpt.com/
PSO Telehealth https://www.psotelehealth.com/
The Future of Dermatology https://thefutureofdermatology.podbean.com/
Evaluating Psoriasis With Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment https://pubmed.ncbi.nlm.nih.gov/15389191/
Functional Genomics in Psoriasis https://pubmed.ncbi.nlm.nih.gov/39000456/
Psoriatic Arthritis https://emedicine.medscape.com/article/2196539-overview
Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era? https://pubmed.ncbi.nlm.nih.gov/39259262/
Automated Triage of Cancer-Suspicious Skin Lesions With 3D Total-Body Photography https://pubmed.ncbi.nlm.nih.gov/41272121/
Current Therapeutic Overview and Future Perspectives Regarding the Treatment of Psoriasis https://pubmed.ncbi.nlm.nih.gov/39405929/
Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum https://pubmed.ncbi.nlm.nih.gov/37115527/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep4-2026a10006hl. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
Lyme Disease https://emedicine.medscape.com/article/330178-overview
Synovial Fluid Eosinophilia in Lyme Disease https://pubmed.ncbi.nlm.nih.gov/3056421/
Rheumatoid Arthritis (RA) Treatment & Management https://emedicine.medscape.com/article/331715-treatment
Psoriatic Arthritis Treatment & Management https://emedicine.medscape.com/article/2196539-treatment#d9
A Review of Biosimilars for Rheumatoid Arthritis https://pubmed.ncbi.nlm.nih.gov/35552095/
Drift, Evolution, and Divergence in Biologics and Biosimilars https://pubmed.ncbi.nlm.nih.gov/24567263/
FDA Updates Guidance on Interchangeability https://www.fda.gov/drugs/drug-alerts-and-statements/fda-updates-guidance-interchangeability
Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention https://pubmed.ncbi.nlm.nih.gov/32205569/
Physicochemical and Biological Similarity Assessment of LBAL, a Biosimilar to Adalimumab Reference Product (Humira®) https://pubmed.ncbi.nlm.nih.gov/34262661/
GP2017, an Adalimumab Biosimilar: Pharmacokinetic Similarity to Its Reference Medicine and Pharmacokinetics Comparison of Different Administration Methods https://pubmed.ncbi.nlm.nih.gov/30698045/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep3-2026a10006hk. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
Psoriasis: An Update on Topical and Systemic Therapies https://pubmed.ncbi.nlm.nih.gov/40568686/
Crosstalk Between White Adipose Tissue and Skin: Unraveling Its Role in Psoriasis Pathogenesis (Review) https://pubmed.ncbi.nlm.nih.gov/40242953/
Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics https://pubmed.ncbi.nlm.nih.gov/30772098/
Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies https://pubmed.ncbi.nlm.nih.gov/32119894/
Oral Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/36751339/
Janus Kinase Inhibitors for Alopecia Areata: A Review of Clinical Data https://pubmed.ncbi.nlm.nih.gov/40433365/
Herpes Zoster https://emedicine.medscape.com/article/1132465-overview
Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay https://www.cdc.gov/tb/hcp/testing-diagnosis/interferon-gamma-release-assay.html
Utility of Repeat Latent Tuberculosis Testing With the QuantiFERON-TB Gold Test in Patients With Psoriasis Treated With Tumour Necrosis Factor-α Inhibitors at a Single U.S. Institution https://pubmed.ncbi.nlm.nih.gov/31452192/
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/
Apremilast in Psoriasis: Current Landscape and Perspectives https://pubmed.ncbi.nlm.nih.gov/40739686/
Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/
Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf
Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39167366/
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/
National Psoriasis Foundation https://www.psoriasis.org/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results https://pubmed.ncbi.nlm.nih.gov/38135800/
Comparing Compliance Patterns Between Randomized Treatments https://pubmed.ncbi.nlm.nih.gov/9204220/
A Scoping Review of Studies Comparing the Medication Event Monitoring System (MEMS) With Alternative Methods for Measuring Medication Adherence https://pubmed.ncbi.nlm.nih.gov/27005306/
A New Taxonomy for Describing and Defining Adherence to Medications https://pubmed.ncbi.nlm.nih.gov/22486599/
One in 3 Prescriptions Are Never Redeemed: Primary Nonadherence in an Outpatient Clinic https://pubmed.ncbi.nlm.nih.gov/18467003/
Data Resource Profile: The Danish National Prescription Registry https://pubmed.ncbi.nlm.nih.gov/27789670/
Tachyphylaxis to Topical Glucocorticoids; What Is the Evidence? https://pubmed.ncbi.nlm.nih.gov/24010503/
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/
10 Tips to Improve Adherence to Immunosuppressive Medication After Kidney Transplantation https://pubmed.ncbi.nlm.nih.gov/40521289/
The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study https://pubmed.ncbi.nlm.nih.gov/28724512/
6MP Adherence in a Multiracial Cohort of Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study https://pubmed.ncbi.nlm.nih.gov/24829202/
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002116. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
expertscape https://expertscape.com/
PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact https://pubmed.ncbi.nlm.nih.gov/40465498/
Topical Corticosteroids https://www.ncbi.nlm.nih.gov/books/NBK532940/
Psoriasis Clinical Guideline https://www.aad.org/member/clinical-quality/guidelines/psoriasis
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/
Keratosis Pilaris https://emedicine.medscape.com/article/1070651-overview
Review of the Mechanism of Action of Coal Tar in Psoriasis https://pubmed.ncbi.nlm.nih.gov/28814117/
Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence https://pubmed.ncbi.nlm.nih.gov/28188596/
Polyaphron Dispersion Technology, a Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application https://pubmed.ncbi.nlm.nih.gov/36050567/
Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits https://pubmed.ncbi.nlm.nih.gov/34106439/
Join Drs Steve Feldman and Alexis Ogdie as they explore digital tools that detect and monitor psoriasis and psoriatic arthritis — using only a smartphone, movement, and a few taps.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002115. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study https://pubmed.ncbi.nlm.nih.gov/38879192/
Psorcast https://apps.apple.com/us/app/psorcast/id1473504102
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings https://pubmed.ncbi.nlm.nih.gov/39301469/
Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis https://pubmed.ncbi.nlm.nih.gov/37127321/
The Impact of Dietary Interventions in Psoriatic Arthritis https://pubmed.ncbi.nlm.nih.gov/37339523/
Dr Feldman is joined by Drs Luke Johnson and Michelle Tarbox of the popular podcast Dermasphere, to discuss trends and hot topics in psoriasis.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002114. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Dermasphere - The Derm Podcast https://dermaspherepodcast.com/
Skincast https://healthcare.utah.edu/dermatology/skincast
Bimekizumab in Patients With Psoriatic Arthritis, Naive to Biologic Treatment: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial (BE OPTIMAL) https://pubmed.ncbi.nlm.nih.gov/36493791/
Inflammatory Bowel Disease Induced by Bimekizumab https://pubmed.ncbi.nlm.nih.gov/35664026/
Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells https://pubmed.ncbi.nlm.nih.gov/32057839/
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives https://pubmed.ncbi.nlm.nih.gov/35769285/
The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy https://pubmed.ncbi.nlm.nih.gov/27474032/
Deucravacitinib Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/
Callus and Its Keratin Before and After Treatment With Acid Sodium Thioglycolate. A Study by Scanning and Conventional Electron Microscopy https://pubmed.ncbi.nlm.nih.gov/5132158/
Join Drs Steven Feldman and John Koo as they discuss psychodermatology and the link between psoriasis, anxiety, depression, and other mental health conditions.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002113. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
Management of Psychodermatologic Disorders https://www.medscape.com/viewarticle/730033_5
Association Between Psoriasis and Depression: A Traditional Review https://pubmed.ncbi.nlm.nih.gov/32944430/
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials https://pubmed.ncbi.nlm.nih.gov/38616886/
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis https://pubmed.ncbi.nlm.nih.gov/23892536/
Biologic Treatments of Psoriasis: An Update for the Clinician https://pubmed.ncbi.nlm.nih.gov/33623366/
Role of Janus Kinase Inhibitors in Therapy of Psoriasis https://pubmed.ncbi.nlm.nih.gov/34640327/
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis With Comorbid Conditions and Special Populations: A Review https://pubmed.ncbi.nlm.nih.gov/33861409/
Depression and Suicidality in Psoriasis and Clinical Studies of Brodalumab: A Narrative Review https://pubmed.ncbi.nlm.nih.gov/31939925/
Use of the Patient Health Questionnaire (PHQ-9) in Practice: Interactions Between Patients and Physicians https://pubmed.ncbi.nlm.nih.gov/32564676/
Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002112. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview
Medscape InDiscussion: Obesity https://www.medscape.com/viewarticle/982631
Update on Obesity in Psoriasis Patients https://pubmed.ncbi.nlm.nih.gov/37895330/
Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 https://www.cdc.gov/nchs/data/databriefs/db508.pdf
Obesity-Related Complications, Healthcare Resource Use and Weight Loss Strategies in Six European Countries: The RESOURCE Survey https://pubmed.ncbi.nlm.nih.gov/37258646/
The Link Between Obesity and the Skin https://pubmed.ncbi.nlm.nih.gov/35369048/
Acanthosis Nigricans https://emedicine.medscape.com/article/1102488-overview
Medications for Obesity: A Review https://pubmed.ncbi.nlm.nih.gov/39037780/
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials https://pubmed.ncbi.nlm.nih.gov/38616886/
Role of the Gut-Brain Axis in Energy and Glucose Metabolism https://pubmed.ncbi.nlm.nih.gov/35474341/
Hidradenitis Suppurativa https://emedicine.medscape.com/article/1073117-overview
Biomarkers of Inflammation in Obesity-Psoriatic Patients https://pubmed.ncbi.nlm.nih.gov/31275060/
Robert Kushner, MD https://drrobertkushner.com/
Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002111. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications https://pubmed.ncbi.nlm.nih.gov/29490358/
Ciclopirox Nail Lacquer Topical Solution 8% in the Treatment of Toenail Onychomycosis https://pubmed.ncbi.nlm.nih.gov/11051136/
Efinaconazole in Onychomycosis https://pubmed.ncbi.nlm.nih.gov/34902110/
Cost Effectiveness of Oral Terbinafine (Lamisil) Compared With Oral Fluconazole (Diflucan) in the Treatment of Patients With Toenail Onychomycosis https://pubmed.ncbi.nlm.nih.gov/11994041/
Prescription Cost-Saving Platforms in Dermatology https://pubmed.ncbi.nlm.nih.gov/39259524/
GoodRx https://www.goodrx.com
Mark Cuban CostPlus Drug Company https://www.costplusdrugs.com/
Drs Steve Feldman and Megan Noe fill in the gaps about pustular psoriasis, a relatively rare but serious condition that can be tough to diagnose.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986155). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Palmoplantar Pustulosis: Current Understanding of Disease Definition and Pathomechanism https://pubmed.ncbi.nlm.nih.gov/32201085/
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655659/
Pathophysiology of Generalized Pustular Psoriasis https://pubmed.ncbi.nlm.nih.gov/36779688/
Trial of Spesolimab for Generalized Pustular Psoriasis https://pubmed.ncbi.nlm.nih.gov/34936739/
Drs Steve Feldman and Andrew Blauvelt have a fascinating chat about contrasts and similarities between biologics and biosimilars, covering pharmacoeconomic and legal differences between the US and Europe.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986154). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future https://pubmed.ncbi.nlm.nih.gov/29549597/
International Psoriasis Council https://psoriasiscouncil.org/
Biosimilars for Psoriasis: Clinical Studies to Determine Similarity https://pubmed.ncbi.nlm.nih.gov/27639072/
Safety, Efficacy and Drug Survival of Biologics and Biosimilars for Moderate-to-severe Plaque Psoriasis https://pubmed.ncbi.nlm.nih.gov/29094341/
Dr Steven R. Feldman and nurse practitioner Lakshi M. Aldredge discuss systemic therapy for psoriasis and how nurse practitioners and physician associates fill an important gap.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986153). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199465/?report=reader
Tumor Necrosis Factor Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK482425/
Deucravacitinib for the Treatment of Psoriatic Disease https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372960/
Drs Steven R. Feldman and Kim A. Papp discuss the expanding universe of opportunities and advances for halting limited psoriasis.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986152). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Trial of Roflumilast Cream for Chronic Plaque Psoriasis https://pubmed.ncbi.nlm.nih.gov/32668113/
Psoriasis in Special Localizations https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330687/
Vitamin D Analogs in the Treatment of Psoriasis: Where Are We Standing and Where Will We Be Going? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219168/
Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986151). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-rich Necrotic Core: Results From a Prospective, Observational Study https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199
Treating the Skin With Biologics in Patients With Psoriasis Decreases the Incidence of Psoriatic Arthritis https://pubmed.ncbi.nlm.nih.gov/34281904/
The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener https://pubmed.ncbi.nlm.nih.gov/14583691/
Dr Steven Feldman and Leah Howard, National Psoriasis Foundation President and CEO, discuss how an unseen and unheard patient population has begun to step out and speak up — at the US Capitol and beyond.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986130). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
National Psoriasis Foundation (NPF) https://www.psoriasis.org/
Management of Psoriasis as a Systemic Disease: What Is the Evidence? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187293/
Psoriasis: Classical and Emerging Comorbidities https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323693/
Host Dr Steven Feldman unpacks years of accrued knowledge on managing psoriasis using biologic therapy, with our special guest Dr Craig Leonardi.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/965167). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review https://pubmed.ncbi.nlm.nih.gov/32121574/
Biologic Treatments of Psoriasis: An Update for the Clinician https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896737/
This podcast has the goods on what oral therapy to recommend for almost any circumstance, even weddings. Drs Steven Feldman and Bruce Strober share a treasure trove of practical wisdom.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/965165). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/
Combining Biologic Therapies With Other Systemic Treatments in Psoriasis: Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation https://jamanetwork.com/journals/jamadermatology/article-abstract/2019961
Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis with Systemic Nonbiologic Therapies https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext
Dr Joel Gelfand talks with host Dr Steven Feldman about why phototherapy is a great tool for treating psoriasis. He shares insights on who can benefit and how to approach patients about it.
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965163). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Plaque Psoriasis Treatment & Management https://emedicine.medscape.com/article/1108072-treatment#d11
Effect of UV-B Phototherapy on Plasma HIV Type 1 RNA Viral Level: A Self-Controlled Prospective Study https://jamanetwork.com/journals/jamadermatology/fullarticle/189280
Effect of Two Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991103/
Dermatologists Steven Feldman and Melinda Gooderham share expert advice and go-to options for topical use in patients with psoriasis.
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965162). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Joint AAD–NPF Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext#secsectitle0050
Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539972/
Optimizing the Use of Topical Agents in Psoriasis https://www.scmsjournal.com/wp-content/uploads/2017/02/v33i2s-Optimizing-the-use-of-Topical-Agents.pdf
What's the best way to screen for common comorbidities in patients with psoriasis, and how do the experts respond when clues of systemic disease show up?
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965161). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.
Resources
Psoriasis https://emedicine.medscape.com/article/1943419-overview#a6
Axial Psoriatic Arthritis: An Update for Dermatologists https://www.jaad.org/article/S0190-9622(20)30959-2/fulltext
Psoriatic Arthritis https://emedicine.medscape.com/article/2196539-overview
Psoriatic Arthritis: State of the Art Review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297592/pdf/clinmed-17-1-65.pdf
Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext
Axial Spondyloarthritis https://ard.bmj.com/content/80/12/1511.long
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727454/pdf/40257_2020_Article_578.pdf
Risankizumab, an IL-23 inhibitor, for Ankylosing Spondylitis: Results of a Randomized, Double-blind, Placebo-Controlled, Proof-of-concept, Dose-Finding Phase 2 Study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104676/pdf/annrheumdis-2018-213328.pdf
Axial Involvement in Psoriatic Arthritis Cohort (AXIS): The Protocol of a Joint Project of the Assessment of SpondyloArthritis International Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721378/pdf/10.1177_1759720X211057975.pdf
Three Multicenter, Randomized, Double-blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis https://onlinelibrary.wiley.com/doi/10.1002/art.40728
Efficacy of Guselkumab on Axial Involvement in Patients With Active Psoriatic Arthritis and Sacroiliitis: A Post-Hoc Analysis of the Phase 3 DISCOVER-1 and DISCOVER-2 Studies https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00105-3/fulltext
Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients With Peripheral Arthritis and Physician-Reported Spondylitis: Post-hoc Analyses From Two Phase III, Multicentre, Double-blind, Placebo-Controlled Studies (PSUMMIT-1/PSUMMIT-2) https://ard.bmj.com/content/75/11/1984.long
BASDAI Calculator https://qxmd.com/calculate/calculator_299/basdai
Effectiveness, Costs and Cost-effectiveness of Chiropractic Care and Physiotherapy Compared With Information and Advice in the Treatment of Non-specific Chronic Low Back Pain: Study Protocol for a Randomised Controlled Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741874/pdf/13063_2017_Article_2351.pdf
Axial Involvement in Psoriatic Arthritis: An Update for Rheumatologists https://www.sciencedirect.com/science/article/pii/S0049017221001190?via%3Dihub
Dactylitis: A Hallmark of Psoriatic Arthritis https://www.sciencedirect.com/science/article/pii/S0049017217306261?via%3Dihub
Psoriasis Workup https://emedicine.medscape.com/article/1943419-workup#c2
Treatment Guidelines in Psoriatic Arthritis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/pdf/kez383.pdf
Risk of Myocardial Infarction in Patients With Psoriasis https://jamanetwork.com/journals/jama/fullarticle/203598
Cardiovascular Disease Prevention for Psoriasis and Psoriatic Arthritis (CP3) https://www.med.upenn.edu/gelfand/research.html
Primary Care-Based Screening for Cardiovascular Risk Factors in Patients With Psoriasis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113692/pdf/BJD-175-348.pdf
Psoriasis: Comorbidities https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/pdf/JDE-48-732.pdf
Changing Health Behaviours in Rheumatology: An Introduction to Behavioural Economics https://www.nature.com/articles/s41584-019-0336-1
The Influence of Body Weight of Patients With Chronic Plaque Psoriasis on Biological Treatment Response https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262805/
What drives patients with psoriasis to seek care? Dr Steven Feldman and Professor Andrew Finlay, inventor of the Dermatology Life Quality Index, explore what matters most to patients.
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965160). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.
Resources
How is the severity of psoriatic arthritis and psoriasis usually assessed? https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed
Dermatology Life Quality Index (DLQI) https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x
Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data https://www.karger.com/Article/FullText/365390
A Changed Life: The Life Experiences of Patients With Psoriasis Receiving Biological Treatment https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/